BSE filing, NSE: DENISCHEM. Summary written from the filing by ALFA Finder's alert engine.
Denis Chem Lab Ltd: key numbers
- Share price
- ₹61.37
- Market cap
- ₹85.16 Cr
- Revenue (annual)
- ₹181.7 Cr
- Net profit (annual)
- ₹8.41 Cr
- P/E (TTM)
- 10.7×Sector 46.5×
- Promoter holding
- 38.98%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Denis Chem Lab Ltd
All →Denis Chem Lab Capital Structure Change
VS Holding BV sold 284,447 shares of Denis Chem Lab Ltd via open market transactions. Post-transaction, its shareholding stands at 14.41%.
- Execution
- September and October 2026
Denis Chem Lab Other Announcement
Denis Chem Lab Ltd has submitted its quarterly shareholding pattern for the quarter ended 30 September 2026, as per regulatory requirements.
Denis Chem Lab Management Change
Denis Chem Lab Limited shareholders approved the re-appointment of Dr. Himanshu C. Patel as Managing Director. His three-year term is effective from August 1, 2026.
- Execution
- 3 years
Denis Chem Lab Other Announcement
Denis Chem Lab Limited's shareholders confirmed the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors. The appointment is for a five-year term ending FY 2030-31.
- Execution
- 5 years
Denis Chem Lab Annual General Meeting
Denis Chem Lab Limited conducted its 45th Annual General Meeting on September 25, 2026. Key businesses transacted included the declaration of a Rs. 2.50 per share dividend and management re-appointments.
Denis Chem Lab Capital Structure Change
VS Holding BV sold 307,594 shares in Denis Chem Lab Ltd, reducing its stake to 16.46%. This disclosure was filed under SEBI SAST regulations.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.